Canaan Partners

Venture capital · San Francisco, California

Founded in 1987, Canaan Partners is a venture capital firm based in San Francisco, California. 85 portfolio companies and 6 recorded rounds are on record.

AUM
$7.0B
Portfolio companies
85
Recorded deals
6
Last investment
Jan 2022

Canaan Partners key facts

  • Canaan Partners is a venture capital firm based in San Francisco, California with 85 tracked portfolio companies.
  • Notable positions include Snyk, Halda Therapeutics, Paxos.
  • PrivateMarketView records 6 deal participations by Canaan Partners.
  • Canaan Partners’s most recent recorded investment was in Jan 2022.
  • The team roster lists 7 people.

About Canaan Partners

Founded in 1987, Canaan Partners is a venture capital firm based in San Francisco, California. The firm seeks to invest in early-stage companies operating in the healthcare and technology sectors. This firm is a Registered Investment Adviser (RIA).

Investment activity

Canaan Partners has no recorded round in the last two years; its 6 recorded rounds date from 2015 to Apr 2023. Across all 6 recorded rounds, 3 were later-stage, 2 were seed and 1 were early-stage. Canaan Partners is recorded as lead on 1 of them. Canaan Partners most often invests alongside Boldstart Ventures (4 shared rounds), Accel (2 shared rounds) and Addition (2 shared rounds). Most recently: Kepler Communications (Series C, Apr 2023) and Snyk (Series F, Jan 2022).

Canaan Partners portfolio at a glance

85 portfolio companies are on record for Canaan Partners, including Snyk, Halda Therapeutics and Paxos.

60 of the 85 carry a recorded valuation.

Canaan Partners team

7 people are on record at Canaan Partners: 6 partners and 1 other. Senior names include Deepak Kamra (General Partner - West Coast), Hrach Simonian (General Partner - West Coast) and Joydeep Bhattacharyya (General Partner - West Coast). 6 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 85 recorded positions
  • ·The 10 latest deals — of 6 rounds
  • ·Watchlist + alerts for Canaan Partners's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

85 companies · priced for members
CompanyValuationRole
Snyk▮▮
Halda Therapeutics▮▮
Paxos▮▮
+ 82 more companies · all 85, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Canaan Partners recent deals

6 recorded
Apr 2023Kepler CommunicationsSeries C▮
Jan 2022SnykSeries F▮
Jun 2021Kepler CommunicationsSeries B▮
+ 3 more deals · amounts and lead flags are a member featureUnlock all 6 deals

Membership and data by Private Market View

Team
7 people on record — 6 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Canaan Partners

What companies does Canaan Partners invest in?
Canaan Partners has 85 recorded portfolio companies, including Snyk, Halda Therapeutics, Paxos.
What is Canaan Partners's AUM?
Canaan Partners manages approximately $7.0B in assets.
Is Canaan Partners actively investing?
Canaan Partners's most recent recorded investment was in Jan 2022.